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Abstract
Background: Weight regain after weight loss is common. In the Diogenes dietary intervention study, high protein and low
glycemic index (GI) diet improved weight maintenance.
Objective: To identify blood predictors for weight change after weight loss following the dietary intervention within the
Diogenes study.
Design: Blood samples were collected at baseline and after 8-week low caloric diet-induced weight loss from 48 women
who continued to lose weight and 48 women who regained weight during subsequent 6-month dietary intervention period
with 4 diets varying in protein and GI levels. Thirty-one proteins and 3 steroid hormones were measured.
Results: Angiotensin I converting enzyme (ACE) was the most important predictor. Its greater reduction during the 8-week
weight loss was related to continued weight loss during the subsequent 6 months, identified by both Logistic Regression
and Random Forests analyses. The prediction power of ACE was influenced by immunoproteins, particularly fibrinogen.
Leptin, luteinizing hormone and some immunoproteins showed interactions with dietary protein level, while interleukin 8
showed interaction with GI level on the prediction of weight maintenance. A predictor panel of 15 variables enabled an
optimal classification by Random Forests with an error rate of 2461%. A logistic regression model with independent
variables from 9 blood analytes had a prediction accuracy of 92%.
Conclusions: A selected panel of blood proteins/steroids can predict the weight change after weight loss. ACE may play an
important role in weight maintenance. The interactions of blood factors with dietary components are important for
personalized dietary advice after weight loss.
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Introduction
The worldwide epidemic of obesity and related health problems
like diabetes [1] and others demands effective measures to help
overweight and obese people to reduce their weight. However, to
maintain a reduced weight is a challenge because the majority of
people regain weight in the long term [2]. Targeting the obesity
problem by dietary intervention, a pan-European project
‘Diogenes’ studied the relative efficacy of four different diets with
variation in protein/carbohydrate content and glycemic index (GI)
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16773with respect to weight loss maintenance [3,4]. It showed that both
a modestly higher protein content and a modest reduction in GI
improve weight loss maintenance [5].
It is well recognised that obesity has both a genetic and an
environmental basis. An individual’s susceptibility is determined in
part by genetics, while the observed outcome is strongly influenced
by environmental factors (diet, physical activity etc.). In addition to
single-gene variants causing obesity [6], there is growing evidence
that gene-environment interactions influence the development of
obesity and the weight change by interventions [7,8,9]. An
accurate assessment of genetic background comes from genotyping
and transcription measurements. However, blood proteins offer an
indirect assessment, since their circulating levels are determined by
genetic and environmental factors.
The development of obesity is a complex physiological process,
so are weight loss and weight maintenance. Previous studies on the
prediction of weight change after weight loss have mostly focussed
on psychological and behavioural aspects [10,11], with some
studies addressing biological aspects [8,12]. Profiling of blood
proteins covering various functions may allow us to predict the
weight maintenance more accurately. Here we investigated the
blood profile of women who participated in the Diogenes dietary
intervention study with 31 proteins and 3 steroid hormones from
various functions that have been shown to be related to obesity.
The profiling of these targeted adipokines, cytokines, inflammation
markers, vascular factors, satiety hormones, sex hormones and
other metabolic hormones, allowed us to evaluate the prediction
power of these blood analytes for weight change after weight loss,
and with respect to possible interaction with dietary protein and
GI levels.
Methods
Participants and study design
The participants were part of the pan-European, randomized
and controlled dietary intervention study Diogenes (http://www.
diogenes-eu.org). The details on design and dietary intervention
were reported previously [3,4]. In brief, from clinical investigation
day (CID) 1, overweight or obese but otherwise healthy subjects
followed an 8-week low calorie diet (LCD) with about 3.3 MJ/d,
and participated in clinical investigation on CID2 at the end of this
weight loss period. Those who achieved $8% loss of initial body
weight were in a 262 factorial design randomized to one of the
following four moderate-fat diets or a control diet to be consumed
ad libitum for 6-month weight maintenance with dietary
counselling every 2–4 weeks [3,4]: low protein (LP) and low GI
(LGI) (LP/LGI), LP and high GI (HGI) (LP/HGI), high protein
(HP) and LGI (HP/LGI), HP and HGI (HP/HGI). Participants
were advised to maintain body weight, but there were no
restrictions with respect to further weight loss. At the end of this
weight maintenance period the participants underwent a further
clinical investigation day (CID3).
On each CID, the anthropometrical and physiological param-
eters were measured, and blood, urine and fat biopsies were taken
using the same standardized protocol at each centre [4]. For the
present research, EDTA plasma and serum samples were obtained
from overnight-fasting participants. The samples were aliquoted
and kept at 280uC during storage and transportation. In addition,
serum glucose, triglycerides, cholesterols, dietary intake based on
food diary, and urinary analysis on 24-hr nitrogen excretion to
assess adherence to the diet were measured as previously described
[3,4,5].
The sample size estimation was done based on the complete
Diogenes study and has been described previously [5]. For reason
of power, we focused on female participants in each of the four
maintenance diet groups. The dietary interventions were com-
pleted by 236 adult Caucasian women who were below 50 years of
age, non-diabetic and non-dyslipidemic with fasting glucose
,7mM, triglyceride ,3.6mM and total cholesterol ,7mM at
CID1. A ‘weight maintenance score’ of relative weight change
over the initial weight loss was calculated to assess the outcome of
weight maintenance. In this way the influence of weight loss on
weight maintenance is taken into account.
Weight maintenance score~
body weight at CID3{body weight at CID2
body weight at CID1{body weight at CID2
The subjects beyond the 10–90 percentiles of the score of each
diet group were considered as the extremes and excluded from this
analysis. From the remaining subjects, the 12 with the lowest
(negative) score were defined as the weight-losers and the 12 with
highest (positive) score as the weight-regainers in each diet group.
In total, 96 subjects were selected for our study.
Measurement of targeted blood factors
We first composed a large list of blood proteins involved in
obesity as reported in the literature, then searched for available
assay methods. The targeted analytes were mainly determined by
its relevance for obesity as described in Text S1.
All the samples were blinded and randomly allocated with
respect to dietary intervention and weight change prior to
transport to the labs for analysis. The majority of the candidates
were analyzed in plasma, unless otherwise stated in serum, by two
multiplex biomarker testing laboratories with Clinical Laboratory
Improvement Amendments (CLIA) certification: Rules Based
Medicine (RBM; Austin, TX, USA) applying their Human
Metabolic Map version 1.0, (http://www.rulesbasedmedicine.
com/products-services/human-metabolic.asp), and SearchLight
(Aushon BioSystems, Woburn, MA, USA) applying a customized
multiplex immunoassay.
Interleukin (IL) 6, IL8 and tumor necrosis factor (TNF) a were
analyzed with Sanquin Pelikine compact human ELISA kits
(Amsterdam, the Netherlands). Amylin (IAPP) was analyzed with
Linco human amylin (total) ELISA kit (St. Charles, MO, USA).
Matrix metalloproteinase 9 (MMP9) was analyzed in serum by
R&D systems Quantikine human MMP-9 (total) immunoassay kit
(Minneapolis, MN, USA). Serum haptoglobin (HPT) was
determined by a clinical immunoturbidimetric method using an
LX-20 analyzer (Beckman-Coulter, Brea, CA, USA). Serum C-
reactive protein (CRP) was quantified by an immunoturbidimetric
assay with monocloncal antibodies (Roche Diagnostics, Hvidovre,
Denmark) using a COBAS Integra 400 analyzer. Fibrinogen (FG)
and coagulation factor VII (F7) concentrations were determined
only at CID1 by measuring the clotting time of the diluted plasma
with the STA-R Evolution Coagulation Analyzer (Diagnostica
Stago, Asnieres Sur Seine, France).
Ethics
The study was approved by local ethical committees in the
respective countries: 1. Medical Ethics Committee of the
University Hospital Maastricht and Maastricht University, the
Netherlands; 2. The Committees on Biomedical Research Ethics
for the Capital region of Denmark, Denmark; 3. Suffolk Local
Research Ethics Committee, United Kingdom; 4. University of
Crete Ethics Committee, Greece; 5. the Ethics Commission of the
Predictors for Weight Loss Maintenance
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16773University of Potsdam; 6. Research Ethics Committee at the
University of Navarra, Spain; 7. Ethical Committee of the Institute
of Endocrinology, Czech Republic; 8. Ethical Committee to the
National Transport Multiprofile Hospital in Sofia, Bulgaria. All
participants signed a written informed consent.
Data analysis
Analytes by multiplex assays were excluded if more than half of
the samples were not measurable on the standard curve or if
controls showed high variation. The final list of included analytes
is shown in Table 1. The values of insulin-like growth factor (IGF)
1 of 16% of the samples and the values of growth hormone (GH)
of 6% of the samples, which were flagged as being below the
detection limit, were imputed with a value of half of the lowest
detected concentration. The data of plasma insulin (INS)
measured by RBM were calibrated using insulin data from a
subset of serum samples measured by a solid-phase, two-site
chemiluminescent immunometric assay (Siemens Medical Solu-
tions Diagnostics, Ballerup, Denmark) using an Immulite 2500
analyzer. Further, outliers defined as a data point out of the
mean64SD range were removed per analyte.
The anthropometrical and physiological parameters were
expressed as mean6SD. Student t-test or Mann-Whitney test
was applied to compare the difference between weight-losers and -
regainers.
Taking weight loss or regain during the 6-month maintenance
period as the outcome, logistic regression with Logit function in
Generalized Linear Model was used to examine blood analytes
one by one with the concentrations at CID1, CID2, and the fold
change during the weight loss period (CID2/CID1) (all Ln-
transformed), with age and the fold change of weight as covariates.
When the interactions of blood analytes with dietary components
were examined, the dietary protein level and GI level were also
included as factors in the regression model. Significant variables
were further used to build multinomial logistic regression models
by backward stepwise modelling, with age and the fold change of
weight always as forced entry variables. Nagelkerke pseudo R
2 was
used to estimate the explained variance by the prediction model.
The above analyses were done with SPSS version 15.0 (SPSS Inc.,
Chicago, IL, USA). A two-sided p-value,0.05 was taken as
significant.
Random Forests (RF) is a supervised non-linear and non-
parametric learning algorithm, which has been successfully applied
to various, especially biological problems and with a good
reputation on accuracy and robustness [13]. In RF, out-of-bag
(oob) error rate estimation warrants no need for cross-validation or
a separate test set to get an unbiased estimation of the test set
error. Mean Decreased Gini (MDG) and Mean Decreased
Accuracy (MDA) are indices of the importance of the variable in
the classification. This was done using ‘randomForest’ package
version 4.5–34 [14] with R version 2.10.1 [15]. Prior to RF
analysis, the missing values were imputed using the Probabilistic
PCA (PPCA) method and all values were normalized by being
Table 1. List of analyzed blood proteins and steroid
hormones.
Category Symbol Name Executed
Sex hormones PRO Progesterone Rules Based
Medicine
TES Testosterone Rules Based
Medicine
LH Luteinizing Hormone Rules Based
Medicine
FSH Follicle Stimulation
Hormone
Rules Based
Medicine
PRL Prolactin Rules Based
Medicine
Other steroid
hormone
COR Cortisol Rules Based
Medicine
Vascular factors ACE Angiotensin I converting
enzyme 1
Rules Based
Medicine
AGT Angiotensinogen Rules Based
Medicine
PAI1 Plasminogen activator
inhibitor-1, active
Aushon
SearchLight
FG Fibrinogen In-house
F7 Coagulation factor VII In-house
Adipokines LEP Leptin Rules Based
Medicine
RETN Resistin Rules Based
Medicine
ASP Acylation stimulation
protein
Rules Based
Medicine
ADIPOQ Adiponectin Rules Based
Medicine
RBP4 Retinol binding protein 4 Aushon
SearchLight
Insulin and related
hormones
INS Insulin Rules Based
Medicine
GCG Glucagon Rules Based
Medicine
IAPP Islet amyloid polypeptide,
amylin, total
In-house
Immunoproteins MIF Macrophage migration
inhibiting factor
Aushon
SearchLight
IL6 Interleukin 6 In-house
IL8 Interleukin 8 In-house
TNFa Tumor necrosis factor alpha In-house
MMP9 Matrix metallopeptidase 9 In-house
1
HPT Haptoglobin In-house
1
CRP C-reactive protein In-house
1
Growth factors GH Growth hormone Aushon
SearchLight
IGF1 Insulin-like growth factor 1 Rules Based
Medicine
VEGFD Vascular endothelial
growth factor-D
Aushon
SearchLight
PEDF Pigment epithelium-derived
factor
Aushon
SearchLight
IGFBP1 Insulin-like growth factor
binding protein 1
Aushon
SearchLight
IGFBP3 Insulin-like growth factor
binding protein 3
Aushon
SearchLight
Satiety hormones GLP1 Glucagon-like Peptide-1,
total
Rules Based
Medicine
Table 1. Cont.
Category Symbol Name Executed
PP Pancreatic polypeptide Rules Based
Medicine
1Analyzed in serum, others in plasma.
doi:10.1371/journal.pone.0016773.t001
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variable with a web server from MetaboAnalyst [16].
Results
Subjects’ characteristics
From the Diogenes dietary intervention study, 96 overweight/
obese but otherwise healthy women (29–49 years of age) who had
most pronounced (but not extreme) continued weight loss or weight
regain after weight loss according to the weight maintenance score,
were selected evenly from 4 dietary groups. Weight-losers lost
3.362.2 kg weight, while weight-regainers regained 3.961.2 kg
weight during the 6-month maintenance period.
Anthropometrical and physiological characteristics were not
different at baseline (CID1) and post-weight loss (CID2), and only
showed a trend (p=0.057) for younger age in the weight-losers
compared to the -regainers (Table 2). During the weight loss
period, the fold change of weight was the only one different,
although borderline, between the weight-losers (0.8960.03) and -
regainers (0.9060.02, p=0.021). Therefore, age and the fold
change of weight were always controlled in the following logistic
regression analyses.
According to the post-intervention dietary record (n=73), the
protein content was 17.864.1 and 20.765.4 energy% for LP and
HP diets, respectively, and the GI was 56.064.6 and 59.564.5 for
LGIandHGIdiets,respectively.There was a modestbutsignificant
difference in dietary protein (p=0.012) and in GI (p=0.002)
betweentheassigned dietarygroups.Thedifferencewereconfirmed
by theurinarynitrogen excretionas a marker of adherenceto HP or
LP diet (13.863.3 and 11.863.3 g/day, p=0.023).
Logistic regression analysis to find predictors
We measured 31 blood proteins and 3 steroid hormones of 96
subjects at two time points before the dietary intervention/weight
maintenance, namely at CID1 and CID2 (Table S1). Together
with the fold changes during weight loss, these variables were
analyzed by logistic regression to look for predictors of weight
change during maintenance.
In the pooled subjects, the fold change of angiotensin I
converting enzyme 1 (ACE, p=0.007), progesterone (PRO,
p=0.024), IGF binding protein 1 (IGFBP1, p=0.032), the
baseline concentrations of MMP9 (p=0.029) and IGFBP1
(p=0.033), and the concentration of testosterone (TES,
p=0.048) at CID2 were significant to predict the outcome of
weight maintenance. In addition, the baseline concentrations of
IL8 (p=0.090) and IAPP (p=0.093), the concentrations of CRP
(p=0.059), macrophage migration inhibiting factor (MIF,
p=0.067), glucagon-like peptide-1 (GLP1, p=0.086) and gluca-
gon (GCG, p=0.086) at CID2, and the fold change of GLP1
(p=0.053), TES (p=0.063) and plasminogen activator inhibitor-1
(PAI1, p=0.074) had a trend towards significance (Figure 1).
When these 15 variables were analyzed by multinomial logistic
regression, 8 were selected as most important independent
variables to build up a prediction model (Table 3 Model 2). This
model can correctly predict 83% of the cases, thus highly increased
the prediction accuracy as compared to 59% with a model using
only age and the fold change of weight (Table 3 Model 1).
RF to find predictors
All 98 blood protein/steroid variables were ranked by their
MDG and MDA for the importance to classify the subjects into
weight-losers or weight-regainers. With the pooled subjects the top
15 most important variables were identified based on MDG,
which is very constant during classification permutation
(Figure 2A). An optimal classification was achieved using this
set of 15 variables, with an error rate of 2461% (Figure 2B).
Overall, there is a strong correlation between the p-value from
the logistic regression assay and the MDG from RF assay
Figure 1. The predicting power of blood analytes for weight loss maintenance by Logistic Regression. Volcano plot of the significance
P-value versus odd ratio exp(B) of blood proteins/steroids for predicting continued weight loss during the 6-month maintenance period by logistic
regression controlled for age and the fold change of weight. The symbols of the analytes are listed in Table 1. Suffix ‘‘_1’’: concentration at CID1, ‘‘_2’’:
concentration at CID2, ‘‘_12’’: the fold change of concentration CID2/CID1. The analytes are grouped as in Table 1 and marked in different shape/
color.
doi:10.1371/journal.pone.0016773.g001
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Model Parameters
pseudo R
2 (Nagelkerke)
model fitting p-value by
Likelihood Ratio Tests Variable
p-value by
Wald Tests Exp(B)
1. Basal model Intercept 0.020
0.108 0.017 age 0.111 0.93
weight_12 0.043 5.3E-09
2. Model without interactions Intercept 0.059
0.653 1.5E-09 age 0.528 0.95
weight_12 0.375 3.1E-06
ACE_12 ,0.001 3.0E-05
MMP9_1 0.002 0.07
TES_2 0.006 22.6
IGFBP1_12 0.007 0.25
MIF_2 0.015 2.40
PAI1_12 0.016 0.40
CRP_2 0.034 2.10
IAPP_1 0.052 0.50
3. Model with only interactions Intercept 0.050
0.468 1.7E-04 [dietprotein=low] 0.011 1.6E+06
[dietGI=low] 0.269 1.94
age 0.006 0.85
R_Weight_12 0.055 1.8E-11
[dietGI=low] * IL8_12 0.012 0.03
IL8_12 0.133 3.08
[dietprotein=low] * LEP_1 0.012 0.02
LEP_1 0.232 2.68
[dietprotein=low] * LH_1 0.035 11.3
LH_1 0.090 0.23
[dietGI=low] * F7_1 0.061 115
F7_1 0.218 0.13
[dietGI=low] * MMP9_12 0.068 12.4
MMP9_12 0.543 0.56
4. Combined model Intercept 0.014
0.835 3.2E-12 [dietprotein=low] 0.129 3.6E+07
[dietGI=low] 0.483 2.46
age 0.051 0.80
Weight_12 0.122 4.2E-20
ACE_12 ,0.001 3.6E-11
MMP9_1 0.005 0.03
CRP_2 0.007 6.69
PAI1_12 0.054 0.33
TES_2 0.072 49.4
IAPP_1 0.079 0.29
[dietGI=low] *IL8_12 0.001 9.6E-06
IL8_12 0.030 24.8
[dietprotein=low] * LH_1 0.010 5.5E+03
LH_1 0.007 2.1E-03
[dietprotein=low] * LEP_1 0.145 0.01
LEP_1 0.190 0.12
Dependent Variable is weight loss vs. weight regain during dietary intervention/maintenance.
The variables of measured blood analytes were Ln-transformed in the model. Suffix ‘‘_1’’: concentration at CID1, ‘‘_2’’: concentration at CID2, ‘‘_12’’: fold change of the
concentration (CID2/CID1). The symbol of blood analytes are listed in Table 1. In model 3 and 4, high dietary protein level and high GI level were reference categories
and their related B=0.
doi:10.1371/journal.pone.0016773.t003
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values). Nine of the top 15 most important variables from RF
overlapped with significant or tending to be significant variables
from logistic regression. The fold change of ACE was identified as
the most important variable by both methods. For the top 5, only
baseline FG is different from the logistic regression outcome. Its
importance is even clearer when MDA is used for ranking.
Because the interactions among variables increase their
importance during making the decision trees, we checked possible
interactions of baseline FG with other variables by logistic
regression and found that it significantly interacts with the fold
change of ACE on the prediction (p=0.023). This interaction was
still significant after controlling for the fold change of body fat
mass (p=0.014) as tested in a subset of subjects who had fat mass
measured (n=59). Based on the median baseline FG values we
split the subjects into a low and a high group. Only in the high FG
group was the fold change of ACE significantly associated with the
outcome of weight maintenance, with a greater reduction in ACE
predicting a greater chance for continued weight loss. In the low
FG group, no difference was observed (Figure 3).
Interaction with dietary protein and GI levels
By logistic regression, luteinizing hormone (LH), CRP, IL6,
HPT, leptin (LEP), vascular endothelial growth factor-D (VEGFD)
and IGFBP3 showed significant interaction with dietary protein
level for the prediction of the weight change during maintenance
(Figure 4A). Remarkably, immunoproteins CRP, IL6 and HPT
showed the interaction either significantly or close to significant at
both CID1 and CID2, and with the same pattern. They were also
all positively correlated with LEP (p,0.002).
IL8, MIF, MMP9 and F7 showed significant interaction with
dietary GI level for the prediction (Figure 4B). Among these
analytes, IL8 and MIF were positively correlated (p,0.001).
A model using the independent interactions with dietary protein
or GI (Table 3 Model 3) can correctly predict 77% of the cases.
Multinomial logistic regression based on all components of model
2 and 3 resulted in a combined model with 9 independent analytes
(Table 3 Model 4). This combined model can correctly predict
92% of the cases.
We also tried to use RF to search for the interactions between
blood analytes and diet components on the prediction. However,
there was no difference for the MDG of variables after taking the
dietary components into the classification forests (p.0.99). This
might be due to the fact that category variables of diet protein and
Figure 2. Top 15 important predictors for weight loss maintenance identified by Random Forest. A. The variables are ranked by the
average of 10 runs on the mean decrease in classification accuracy (MDA) or by the mean decrease in classification Gini impurity (MDG). Suffix ‘‘_1’’:
concentration at CID1, ‘‘_2’’: concentration at CID2, ‘‘_12’’: fold change of the concentration (CID2/CID1). The symbol of blood analytes are listedi n
Table 1. B. Classification plot of continued weight-losers (red dots) and weight-regainers (blue triangles) during weight maintenance in pooled
subjects (n=96) by the top15 important variables.
doi:10.1371/journal.pone.0016773.g002
Figure 3. The relation between weight maintenance score and
the fold change of ACE during weight loss. Boxplot shows the
quartile range of weight maintenance score with outliers (in circle)
across tertile of the fold change of ACE during weight loss, for subjects
with low (#9.6mmol/L, n=48, blank bar) and with high (.9.6 mmol/L
n=47, grey bar) baseline fibrinogen level. The variation of weight
maintenance score attributed to the fold change of ACE, p=0.478 in
low group and p=0.014 in high group, was tested by one-way ANOVA
controlled for age and the fold change of weight, and Bonferroni test
for multiple comparisons. *T3 significantly different from T1 in high
fibrinogen group, p=0.013.
doi:10.1371/journal.pone.0016773.g003
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variables [17].
Correlations with ACE
Because ACE was identified as the most important predictor
among all candidates, we checked for its relation with measures of
obesity and other blood analytes (Table 4). It showed that ACE
positively correlated to body weight (p=0.036), body mass index
(BMI, p=0.024) and fat mass (p=0.007) at baseline, but not
significant anymore after weight loss. However, the contribution of
the fold change of ACE to the prediction was still significant
(p=0.018) after controlling for baseline body fat mass in a subset
of the cohort (n=78), or close to significant (p=0.086) after
controlling for the fold change of fat mass (n=60), while fat mass
itself had no effect on the prediction (p.0.5).
All measured peptide sex hormones, satiety hormones and
insulin related hormones, but not insulin itself, were positively
correlated with ACE. For most proteins this correlation concerned
their fold changes. Except for PAI1, all those factors are low
molecular weight proteins/peptides.
Discussion
An important role of ACE in weight maintenance
ACE is a zinc metallopeptidase and catalyses the hydrolysis of
dipeptides or tripeptides from the carboxyl terminus of oligopep-
tides [18]. Its most well-known product is angiotensin II from the
substrate angiotensinogen, forming the renin-angiotensin system,
which contributes to increased blood pressure and retains salt and
water [19]. The genetic polymorphisms in this gene, which highly
influence the ACE circulating level [20], have been repeatedly
found to be associated with measures of obesity [6]. Our data
support this. We observed that moderate weight loss by LCD
significantly decreased ACE concentration about 12%, which is in
line with previously reported decreased ACE activity in over-
weight/obese woman (about 12%) [21], and in mixed male and
female obese adults (about 20%) by weight loss [22]. The relation
between ACE and obesity has been suggested to lie in the local
expression of the renin-angiotensin system and the possible trophic
role of angiotensin II in the development of adipose tissue [23,24].
Moreover, its role in water retention may also contribute to
regulation of body weight gain.
In the present study we showed correlations between ACE and
sex hormones, satiety hormones, insulin related hormones, LEP
and other blood metabolic proteins, suggesting its broad range of
substrates and involved pathways. Indeed, ACE was found to be
able to process gonadotropin-releasing hormone (LHRH) in vitro,
thus possibly regulating both LH and follicle-stimulating hormone
levels [25]. Also satiety hormones and GCG need to be
proteolytically processed to become active [26,27]. But it is yet
unknown if ACE plays a role in this process or not. Moreover, the
prediction by ACE was independent of body weight and fat mass.
Figure 4. Predictors having interaction with dietary components for the outcome of weight maintenance. Boxplots show the quartile
range of the blood analytes without outliers for continued weight-losers (blank bar) and weight-regainers (grey bar) in each dietary group. The p-
value above the chart is the significance of the interaction between dietary protein/GI and the concentration/change of the blood analyte with
respect to the outcome of weight maintenance (weight-loss or -regain). The p-values under the chart is the significance of the prediction of the
variable inside the subgroups. All were obtained by logistic regression (controlled for age and the fold change of weight). A. predictors having
interaction with dietary protein levels. LP: low protein, HP: high protein. B. predictors having interaction with dietary glycemic index (GI) levels. LGI:
low GI, HGI: high GI.
doi:10.1371/journal.pone.0016773.g004
Table 4. Significant correlations between ACE and measures of obesity and other blood analytes.
Length
1 CID1 CID2 CID2/CID1
Category Analyte (AA) r p-value r p-value r p-value
Body adiposity BMI - 0.231 0.024 0.131 0.203 0.186 0.070
weight - 0.215 0.036 0.099 0.337 0.186 0.070
Fat mass (%)
2 - 0.304 0.007 0.202 0.086 20.116 0.376
Sex hormones FSH 92/111 0.198 0.053 0.024 0.813 0.463 2.0E-06
LH 92/121 0.282 0.005 0.198 0.053 0.348 5.2E-04
PRL 199 0.217 0.035 0.192 0.063 0.396 7.1E-05
Satiety factors PP 36 0.220 0.031 0.251 0.014 0.263 0.010
GLP1 37 0.196 0.056 0.135 0.189 0.329 0.001
Insulin related
hormones
GCG 29 0.242 0.017 0.184 0.073 0.320 0.002
IAPP 37 0.156 0.136 0.034 0.750 0.403 8.1E-05
Others LEP 146 0.219 0.032 0.055 0.592 0.377 1.5E-04
IL6 183 0.156 0.129 20.024 0.818 0.256 0.012
VEGFD 117 20.134 0.192 20.115 0.266 20.289 0.005
PAI1 379 0.242 0.018 0.017 0.870 0.130 0.205
Analyzed by Pearson correlation. Data of blood analytes were Ln transformed before analysis. r: correlation coefficient, p: significance. The significant p-values (,0.05)
are marked as bold.
1The length of the (main) active processed chain is resourced from the UniProt Knowledgebase (http://beta.uniprot.org/uniprot/).
2Subjects used in the analysis with respect to fat mass measured at CID1 n=78, at CID1 n=73, and the fold change CID2/CID1 n=60. For other analytes subjects n=96.
doi:10.1371/journal.pone.0016773.t004
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and weight regain touches a complex network, not only involving
adipose tissue development, but also water and sodium retention,
and possibly satiety hormone regulation to control energy intake.
It is further known that ACE is abundant in the hypothalamus
[28]. A recent observation on the crosstalk between ACE and
uncoupling protein-2 (UCP2) in human umbilical vein endothelial
cells [29] may support this, because UCP2 in the hypothalamus
regulates the function of neurons involved in food intake during
fasting [30].
Here for the first time, we found that neither the baseline level,
nor the post-weight-loss level, but the extent of the reduction of
ACE during weight loss discriminates between subjects who will
continue to lose weight and those who will regain weight during
the 6-month weight maintenance period. A greater reduction in
ACE predicts a greater chance for continued weight loss.
However, the predicting power of the fold change of ACE alone
is limited due to a large overlap between weight-losers and -
regainers. Apparently, more processes in the body are involved in
weight regain/maintenance than the range of pathways that ACE
may cover.
We also reported a novel interaction between ACE and FG,
namely the prediction power of ACE is only observed in subjects
with high baseline FG. FG is the key component of blood
coagulation, but it is also an anti-inflammatory acute phase protein
[31] and can serve as a biomarker for obesity [32]. Among other
inflammation-related proteins, baseline levels of IL6, MMP9, MIF
and HPT were also shown to interact with the fold change of ACE
(p=0.003, 0.026, 0.028 and 0.028, respectively) with the same
pattern as FG, but IL8, CRP and TNFa did not. While the
induction of factors like CRP requires various signals including
TNFa, induction of FG only requires IL6 [31]. This suggests that
an IL6-mediated inflammation state may amplify the role of ACE
in weight maintenance.
Interactions between blood analytes and dietary
components
Our findings show that the prediction can be manipulated by
the dietary protein and GI intake during the weight maintenance
period. We did not perform multiple testing corrections, but the
repeatedly detected similar interaction of analytes from the same
functional group may secure the finding. This is the case for the
interaction between dietary protein level and immunoproteins
(IL6, CRP and HPT). The interactions between GI level and other
immunoproteins IL8, MIF and MMP9 were not consistent.
Therefore we only discuss the role of dietary protein in weight
maintenance. Our results suggest that in order to prevent weight
regain, subjects with a high baseline level of LEP, IL6, CRP and
HPT should follow a HP diet, and subjects with a low baseline
level are most likely to succeed with a LP diet.
In the Diogenes study, the fat content was kept relatively
constant among diets. As a consequence HP diets also mean low
carbohydrate diets [3,5]. Thus, the aforementioned interaction
with dietary protein level might also be interpreted as the
interaction with dietary carbohydrate level. During the weight
maintenance after weight loss, adipocytes try to recover energy
storage by increasing the uptake of glucose and fat [33]. But also
immune responses are energy expensive processes and glucose is
the preferred energy fuel [34,35]. When there is a competition for
glucose, the survival related immune system may have priority
over the storage function of adipocytes. With LP (high carbohy-
drate) diets, there might be no energy competition and adipocytes
can dominate the fuel flow. With HP (low carbohydrate) diets,
there is energy competition and the immune system can dominate
the fuel flow.
LEP represents the amount/size of adipocytes and/or activity of
adipose tissue, confirmed by the strong correlation between LEP
and fat mass at baseline in our study (r=0.595, p,0.001). As
expected, the interaction between LEP and dietary protein level
lost significance (p=0.190) if we add the interaction between fat
mass and dietary protein level (p=0.418) in the model. Thus
subjects with high LEP level taking LP diet will easily recover
energy storage without fuel flow restriction. The relation between
immunoproteins and weight regain may also be a secondary effect,
because immune system and adipocytes/adipose tissue are
positively associated, confirmed by strong correlations between
LEP and immunoproteins in our study. Also their interactions with
dietary protein were not independent from each other. For
subjects with profound/active fat mass, a HP diet is preferred to
prevent weight regain.
Limitations and Conclusions
Because obesity and weight regulation is complex, a panel of
predictors covering various processes performs better than one or
two predictors on the prediction of weight change after weight loss.
A logistic regression model with 9 independent predictors has an
accuracy of prediction of .90%. However, such self evaluation is
too optimistic. RF gave a more realistic evaluation with a
moderate accuracy of 76% by a 15-predictor panel. The present
study was conducted on a limited number of adult females
extracted from a pan-European project. Therefore, our findings
should be validated in other cohorts and also in males.
Nevertheless, the information about 34 blood proteins/steroids,
particularly the importance of ACE, and the interaction between
dietary protein/carbohydrate level and LEP and immunoproteins,
may help to develop personalized programmes to improve weight
maintenance.
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